Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Deferred Taxes (2021 - 2026)

Neogen's quarterly Deferred Taxes came in at -$4.3 million in Q1 2026, up 53.47% year-on-year from -$2.8 million in Q1 2025, and up 20.93% quarter-over-quarter from -$5.4 million in Q4 2025.

Neogen has reported Deferred Taxes for 6 years, with the latest figure at -$4.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Deferred Taxes rose 53.47% year-over-year to -$4.3 million; the trailing twelve-month figure through Feb 2026 stood at -$40.2 million (up 33.71% YoY), and the FY2025 full-year result was -$57.8 million, down 110.71% from the prior year.
  • Deferred Taxes for Q1 2026 stood at -$4.3 million, up from -$5.4 million in the prior quarter.
  • The five-year high for Deferred Taxes was $998000.0 in Q3 2023, with the low at -$27.5 million in Q2 2024.
  • Average Deferred Taxes over 5 years is -$7.3 million, with a median of -$4.3 million recorded in 2026.
  • Year-over-year, Deferred Taxes plunged 9493.33% in 2022 and soared 169.35% in 2023.
  • Tracing NEOG's Deferred Taxes over 5 years: stood at -$544000.0 in 2022, then soared by 133.09% to $180000.0 in 2023, then slumped by 8325.0% to -$14.8 million in 2024, then soared by 63.53% to -$5.4 million in 2025, then advanced by 20.93% to -$4.3 million in 2026.
  • The last three Deferred Taxes figures came in at -$4.3 million (Q1 2026), -$5.4 million (Q4 2025), and -$5.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -33.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -16.70 Mn
10 Neogen 1.94 Bn 1.78 Bn 99.00 Mn -4.27 Mn

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 -4.27 Mn
Nov 30, 2025 -5.40 Mn
Aug 31, 2025 -5.83 Mn
May 31, 2025 -24.68 Mn
Feb 28, 2025 -9.18 Mn
Nov 30, 2024 -14.81 Mn
Aug 31, 2024 -9.12 Mn
May 31, 2024 -27.52 Mn
Feb 29, 2024 -1.08 Mn
Nov 30, 2023 180,000.00
Aug 31, 2023 998,000.00
May 31, 2023 -13.93 Mn
Feb 28, 2023 -3.32 Mn
Nov 30, 2022 -544,000.00
Aug 31, 2022 -1.44 Mn
May 31, 2022 -3.98 Mn
Feb 28, 2022 -632,000.00
Nov 30, 2021 -73,000.00
Aug 31, 2021 -15,000.00